04 Sep, 2025

Permira funds to buy into RightShip; Thompson Street sells Freddy's

Deal Wrap is updated as of 3 p.m. ET.

– Funds advised by Permira Advisers Ltd. will acquire a minority stake in maritime digital platform RightShip Pty. Ltd. Founding RightShip shareholders BHP Group Ltd., Cargill Inc. and Rio Tinto Group will continue to own their equal stakes in the business. Rothschild & Co was financial adviser to RightShip and its shareholders on the deal, which is pending regulatory approvals.

– Thompson Street Capital Partners sold fast-casual restaurant operator Freddy's LLC to Rhone Group LLC's fund affiliates. William Blair was the lead financial adviser to Freddy’s, and North Point was a financial adviser. Jefferies LLC was Rhône's financial adviser.

Rainier Partners LP acquired a stake in Kleen-Tech Services LLC, a janitorial services provider operating in more than 30 US states.

– Threat intelligence platform Q6 Intelligence LLC, doing business as Q6 Cyber, secured strategic growth funding from Charlesbank Capital Partners LLC's Charlesbank Technology Opportunities Fund LP. AGC Partners was Q6's financial adviser on the transaction, and Lowenstein Sandler was legal counsel. Mintz was legal counsel for Charlesbank.

– Atlassian Corp. agreed to buy The Browser Co. of New York Inc., which is behind the Dia and Arc browsers, from an investor group including Pace Capital and Next Play Ventures LLC. The cash deal, worth about $610 million, is likely to close during the second quarter of Atlassian's fiscal year 2026.

– Tecum Capital Management Inc. received a minority investment from private equity peer Cantilever Group. Republic Capital Group advised Tecum on the transaction.

– Durational Capital Management LP made a growth investment in independent beer brand Garage Beer Inc. Centerview Partners LLC is financial adviser and Sidley Austin LLP is legal adviser to Garage Beer on the transaction. Davis Polk & Wardwell LLP is Durational Capital's legal adviser.

– Clinical-stage biotechnology company Enveda Therapeutics Inc. raised $150 million in a series D funding round led by Premji Invest, alongside new and existing investors.

Disclaimer: This content may be AI-assisted and is composed, reviewed, edited and approved by a human at S&P Global.

For more private equity deals, read our latest In Play report, which looks at potential private equity-backed M&A, including rumored transactions, each week.